Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Seres Therapeutics (MCRB) over the last 10 years, with Q3 2025 value amounting to 0.0.

  • Seres Therapeutics' Asset Utilization Ratio rose 85546.1% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 85546.1%. This contributed to the annual value of 0.36 for FY2023, which is 166286.38% up from last year.
  • Latest data reveals that Seres Therapeutics reported Asset Utilization Ratio of 0.0 as of Q3 2025, which was up 85546.1% from 0.0 recorded in Q3 2024.
  • Seres Therapeutics' 5-year Asset Utilization Ratio high stood at 0.47 for Q3 2021, and its period low was 0.0 during Q3 2024.
  • For the 5-year period, Seres Therapeutics' Asset Utilization Ratio averaged around 0.22, with its median value being 0.22 (2021).
  • The largest annual percentage gain for Seres Therapeutics' Asset Utilization Ratio in the last 5 years was 172210.69% (2024), contrasted with its biggest fall of 9992.28% (2024).
  • Over the past 5 years, Seres Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.39 in 2021, then tumbled by 94.41% to 0.02 in 2022, then skyrocketed by 1525.37% to 0.35 in 2023, then crashed by 99.93% to 0.0 in 2024, then surged by 855.46% to 0.0 in 2025.
  • Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q3 2024 and 0.0 in Q2 2024.